1. First-Line FCR: Effect of del(17p) on PFS and OS

2. Initial Assessments in Newly Diagnosed CLL

3. First-Line FCR: Effect of MRD on PFS and OS

4. First-Line BR vs FCR: Efficacy and Tolerability in Older Patients

5. First-Line Ibrutinib vs Chlorambucil in Older Patients

6. Long-Term Follow-Up of First-Line Ibrutinib in Older Patients

7. Treatment Options After First-line Ibrutinib

8. Minimizing Bleeding Risk in Patients Treated With Ibrutinib

9. Lymphocytosis in Patients Treated With Ibrutinib

10. Importance of Adherence to Ibrutinib Therapy: Analysis of Patients With R/R CLL

11. Abbreviations